Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Creo Medical Group's share price for the quarter that ended in Dec. 2023 was £0.46. Creo Medical Group's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 361.25 Mil. Therefore, Creo Medical Group's market cap for the quarter that ended in Dec. 2023 was £166.18 Mil.
Creo Medical Group's quarterly market cap
increased
from Dec. 2022 (£45.84 Mil) to Jun. 2023 (£122.81 Mil) and
increased
from Jun. 2023 (£122.81 Mil) to Dec. 2023 (£166.18 Mil).
Creo Medical Group's annual market cap
declined
from Dec. 2021 (£269.84 Mil) to Dec. 2022 (£45.84 Mil) but then
increased
from Dec. 2022 (£45.84 Mil) to Dec. 2023 (£166.18 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Creo Medical Group's Enterprise Value for Today is £121.74 Mil.
Creo Medical Group Market Cap Historical Data
The historical data trend for Creo Medical Group's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Creo Medical Group's Market Cap
For the Medical Devices subindustry, Creo Medical Group's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Creo Medical Group's Market Cap Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Creo Medical Group's Market Cap distribution charts can be found below:
* The bar in red indicates where Creo Medical Group's Market Cap falls into.
Creo Medical Group Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Creo Medical Group's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Creo Medical Group (LSE:CREO) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Creo Medical Group Market Cap Related Terms
Thank you for viewing the detailed overview of Creo Medical Group's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Creo Medical Group (LSE:CREO) Business Description
Creo Medical Group PLC is a medical device company engaged in providing services in the field of surgical endoscopy. The company has developed a platform called Croma which is an electrosurgical platform to deliver microwave and bipolar radiofrequency through a single accessory port. The reportable segment of the company is the research and development of electrosurgical medical devices relating to the field of surgical endoscopy.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LSE:CREO has been successfully added to your 